-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Htg Molecular Diagnostics, Inc quarterly/annual Operating Income (Loss) history and growth rate from 2014 to 2022.
- Htg Molecular Diagnostics, Inc Operating Income (Loss) for the quarter ending March 31, 2023 was -$5.01M, a 19.9% increase year-over-year.
- Htg Molecular Diagnostics, Inc Operating Income (Loss) for the twelve months ending March 31, 2023 was -$19.6M, a 0.47% decline year-over-year.
- Htg Molecular Diagnostics, Inc annual Operating Income (Loss) for 2022 was -$20.8M, a 16.9% decline from 2021.
- Htg Molecular Diagnostics, Inc annual Operating Income (Loss) for 2021 was -$17.8M, a 9% increase from 2020.
- Htg Molecular Diagnostics, Inc annual Operating Income (Loss) for 2020 was -$19.6M, a 3.3% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)